
Ligature Therapeutics
Email address and contacts
Ligature Therapeutics company description
Ligature Therapeutics (LTx) is an early-stage biotech company generating targeted protein degraders (TPD). LTx is advancing its structure agnostic fragment-based drug discovery platform to generate cancer-selective TPDs, and has achieved early proof of concept with a lead asset. Ligature Therapeutics was an A*STAR (EDDC) spin-off company founded in 2020 with investment from Lightstone Singapore and SEEDS Capital.
Employee count
1-10
Industry
Biotechnology ResearchHeadquarter address
Singapore, SG
Country
Singapore
Founded
2020
Company website
https://ligaturetx.com






